Severe pertussis in infants: Estimated impact of first vaccine dose at 6 versus 8 weeks in Australia

Alice Ruth Foxwell, Peter McIntyre, Helen Quinn, Katrina Roper, Mark S. Clements

    Research output: Contribution to journalArticlepeer-review

    28 Citations (Scopus)

    Abstract

    We estimated the potential benefits of advancing the first dose of pertussis vaccine for infants from 8 to 6 weeks of age, using Australian national disease databases. Infants had notification rates 3-fold greater than the general population and accounted for 52% of recorded hospitalizations. Infants 1 and 2 months of age had notification rates 3.5 times (95% CI: 2.7-4.5) higher than infants 3 to 11 months of age. Estimation of acceleration of the vaccine to 6 weeks of age reduced average notifications, hospitalizations, and hospital bed-days by 8%, 9%, and 12%, respectively, with larger reductions in an epidemic year.

    Original languageEnglish
    Pages (from-to)161-163
    Number of pages3
    JournalPediatric Infectious Disease Journal
    Volume30
    Issue number2
    DOIs
    Publication statusPublished - Feb 2011

    Fingerprint

    Dive into the research topics of 'Severe pertussis in infants: Estimated impact of first vaccine dose at 6 versus 8 weeks in Australia'. Together they form a unique fingerprint.

    Cite this